These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 251249)

  • 1. Relationship between length of time and contamination in open intravenous solutions.
    Amonsen S; Gren JE
    Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: 'Relationship between Length of Time and Contamination in Open Intravenous Solutions'.
    McGrory A
    Nurs Res; 1979; 28(5):281. PubMed ID: 257404
    [No Abstract]   [Full Text] [Related]  

  • 4. Compatibility and stability of diazepam injection following dilution with intravenous fluids.
    Morris ME
    Am J Hosp Pharm; 1978 Jun; 35(6):669-72. PubMed ID: 665679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrogenic reactions and hemorrhage associated with intrinsic exposure to endotoxin-contaminated intravenous solutions.
    Daufenbach LZ; Alves WA; de Azevedo JB; Arduino MJ; Forster TS; Carmo EH; Hatch DL
    Infect Control Hosp Epidemiol; 2006 Jul; 27(7):735-41. PubMed ID: 16807850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two methods for detecting microbial contamination in intravenous fluids.
    Posey LM; Nutt RE; Thomson PD
    Am J Hosp Pharm; 1981 May; 38(5):659-62. PubMed ID: 6792910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endemic intravenous fluid contamination in pediatric wards].
    Muñoz JM; Zapién R; Ponce-De-León S; Alvarez JA; Mosqueda JL; Gallaga JC; Macías AE
    Rev Invest Clin; 2009; 61(5):378-82. PubMed ID: 20184097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
    Reiter PD; Robles J; Dowell EB
    Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of inadvertent microbial contamination of dextrose solutions.
    Mendie UE; Hugbo PG; Nasipuri RN
    West Afr J Med; 1996; 15(4):190-5. PubMed ID: 9020594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.
    Cloyd JC; Bosch DE; Sawchuk RJ
    Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of intravenous infusion fluids manufactured in Kenya.
    Aluoch-Orwa JA; Ondari CO; Kibwage IO; Hoogmartens J
    East Afr Med J; 1995 Dec; 72(12):800-4. PubMed ID: 8689981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of plastic containers for intravenous solutions.
    Kerkhof K
    Am J Hosp Pharm; 1979 Aug; 36(8):1028, 1035-6. PubMed ID: 484558
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump.
    Mitrano FP; Baptista RJ; Newton DW; Augustine SC
    Am J Hosp Pharm; 1986 Jan; 43(1):78-80. PubMed ID: 3953587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.